Top Story

Spark Therapeutics reports $16.9 million net loss in third quarter

November 25, 2015

Spark Therapeutics reported a net loss of $16.9 million, or $0.70 per basic and diluted share, in the third quarter compared with a net loss of $6.8 million, or $1.22 per basic and diluted share, in the same quarter of 2014, according to a press release.

Revenue was reported at $1.3 million in the third quarter compared with no revenue reported in the same quarter of 2014. The increase was attributed to a collaboration with Pfizer.

Meeting News CoverageVideo

VIDEO: Surgeon's experience — Toric lenses improve astigmatism correction

November 25, 2015
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Rex Hamilton, MD, MS, FACS, discusses how the availability of Tecnis toric lenses (Abbott Medical…
Meeting News Coverage

AAO launches effort to rebrand itself as vanguard of eye care

November 24, 2015
The American Academy of Ophthalmology is embarking on an initiative to rebrand itself and foster an understanding of the specialty’s impact on society, a speaker…
FDA News

AGTC receives orphan drug designation for gene therapy to treat achromatopsia

November 24, 2015
The FDA has granted orphan drug designation to AGTC’s gene therapy product candidate for the treatment of achromatopsia caused by mutations in the CNGA3 gene…

BLOG: How to keep doctor workload, compensation and other squabbles from killing your group practice, part 4

November 24, 2015
There are practical limits to what even the most astute practice administrator can do to get practice partners to the negotiating table on these tough issues…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Vitreomacular Adhesion: Addressing Patient Selection and Safety Concerns for Optimal Treatment

This activity is supported by an educational grant from ThromboGenics.

Clinicians gained a new option for the management of vitreomacular adhesion in 2012 with the FDA approval of a…
More »
Meeting News Coverage Video

VIDEO: Shire VP gives company business update

November 24, 2015
More »